• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

267.2300 USD 1.0200 0.38%

As of 20:10:00 ET on 08/19/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 266.9200 High - Low: 267.8800 - 264.6100 Primary Exchange: NASDAQ GM
Volume: 959,058 52-Week Range: 187.1301 - 275.4000 Beta vs XNBI: 1.0003

ETF Chart for IBB

No chart data available.
  • IBB:US 267.3900
  • 1D
  • 1M
  • 1Y
266.2100
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-08-19) 267.5000
Assets (M) (on 2014-08-19) 5,309.9470
Shares out (M) 19.85
Market Cap (M) 5,304.52
% Premium -0.10
Average 52-Week % Premium 0.0001
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.15%

Performance for IBB

1-Month +6.73% 1-Year +43.04%
3-Month +15.61% 3-Year +44.82%
Year To Date +17.87% 5-Year +28.39%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 08/18/2014
Name Position Value % of Total
Gilead Sciences Inc 4,892,541 492,825,655 9.104%
Celgene Corp 5,192,749 474,149,911 8.759%
Amgen Inc 3,425,500 456,345,110 8.430%
Biogen Idec Inc 1,244,083 428,711,002 7.919%
Alexion Pharmaceuticals Inc 2,183,762 371,763,643 6.867%
Vertex Pharmaceuticals Inc 2,749,262 251,007,621 4.637%
Regeneron Pharmaceuticals Inc 647,191 226,167,367 4.178%
Illumina Inc 1,255,369 216,274,971 3.995%
Mylan Inc/PA 3,985,987 185,268,676 3.422%
BioMarin Pharmaceutical Inc 1,735,314 117,983,999 2.179%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil